Cited by 5,983SARS-CoV-2 and COVID-19 ResearchEnzyme Structure and FunctionAnimal Virus Infections Studies

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Open access

Lan, Jun, Ge, Jiwan, Yu, Jinfang, Shan, Sisi, Zhou, Huan, Fan, Shilong, Zhang, Qi, Shi, Xuanling, Wang, Qisheng, Zhang, Linqi, Wang, Xinquan·2020·Nature

DOI 10.1038/s41586-020-2180-5

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from December 2019 that quickly spread nationwide and to other countries around the world 1-3. Here, to better understand the initial step of infection at an atomic level, we determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor 4. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses 1-3,5. The epitopes of two SARS-CoV antibodies that target the RBD are also analysed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2180-5

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citation
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citation
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citation
La certeza de lo impredecible
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,292
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961

Show all 38 references

Sorted by citations

Items 901–1,000 of 1,026

Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design
Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020) · Vaccines · doi:10.3390/vaccines8030355 · Cited by 60
Insights on cross-species transmission of SARS-CoV-2 from structural modeling
Rodrigues, J., Barrera-Vilarmau, S., Teixeira, J. M. C., Sorokina, M., Seckel, E., Kastritis, P. L., & Levitt, M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008449 · Cited by 60
Recombination events are concentrated in the spike protein region of Betacoronaviruses
Bobay, L., O’Donnell, A. C., & Ochman, H. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009272 · Cited by 60
Amantadine Inhibits SARS-CoV-2 In Vitro
Fink, K., Nitsche, A., Neumann, M., Grossegesse, M., Eisele, K., & Danysz, W. (2021) · Viruses · doi:10.3390/v13040539 · Cited by 60
Sphingolipids as Modulators of SARS-CoV-2 Infection
Törnquist, K., Asghar, M. Y., Srinivasan, V., Korhonen, L., & Lindholm, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.689854 · Cited by 60
Plasmonic Biosensor Augmented by a Genetic Algorithm for Ultra-Rapid, Label-Free, and Multi-Functional Detection of COVID-19
Li, D., Zhou, H., Hui, X., He, X., & Mu, X. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01078 · Cited by 60
Self-citation
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
Trougakos, I. P., Terpos, E., Zirou, C., Sklirou, A. D., Apostolakou, F., Gumeni, S., Charitaki, I., Papanagnou, E., Bagratuni, T., Liacos, C., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02090-6 · Cited by 60
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
Gao, S., Huang, T., Song, L., Xu, S., Cheng, Y., Cherukupalli, S., Kang, D., Zhao, T., Sun, L., Zhang, J., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.027 · Cited by 60
Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
Bohnacker, S., Hartung, F., Henkel, F. D. R., Quaranta, A., Kolmert, J., Priller, A., Ud‐Dean, M., Giglberger, J., Kugler, L. M., Pechtold, L., et al. (2022) · Mucosal Immunology · doi:10.1038/s41385-021-00482-8 · Cited by 60
Understanding COVID-19 in children: immune determinants and post-infection conditions
Rotulo, G. A., & Palma, P. (2023) · Pediatric Research · doi:10.1038/s41390-023-02549-7 · Cited by 60
Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666693 · Cited by 60
Integrins: An Important Link between Angiogenesis, Inflammation and Eye Diseases
Mrugacz, M., Bryl, A., Falkowski, M., & Zorena, K. (2021) · Cells · doi:10.3390/cells10071703 · Cited by 60
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2
Jiang, S., Zhang, X., & Du, L. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1820482 · Cited by 60
Hypernatremia—A Manifestation of COVID-19: A Case Series
Zimmer, M. A., Zink, A. K., Weißer, C. W., Vogt, U., Michelsen, A., Priebe, H., & Mols, G. (2020) · A&A Practice · doi:10.1213/xaa.0000000000001295 · Cited by 59
In-silico design of a potential inhibitor of SARS-CoV-2 S protein
Jaiswal, G., & Kumar, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240004 · Cited by 59
Insights into SARS-CoV-2’s Mutations for Evading Human Antibodies: Sacrifice and Survival
Luan, B., & Huynh, T. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00311 · Cited by 59
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
Cerutti, G., Rapp, M., Guo, Y., Bahna, F. A., Bimela, J. S., Reddem, E. R., Yu, J., Wang, P., Liu, L., Huang, Y., et al. (2021) · Structure · doi:10.1016/j.str.2021.05.014 · Cited by 59
Self-citation
Preliminary Structural Data Revealed That the SARS‐CoV‐2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity
Khan, A., Wei, D., Kousar, K., Abubaker, J. A., Ahmad, S., Ali, J., Al‐Mulla, F., Ali, S. S., Nizam‐Uddin, N., Sayaf, A. M., et al. (2021) · ChemBioChem · doi:10.1002/cbic.202100191 · Cited by 59
A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
Nassar, A. M., Ibrahim, I. M., Amin, F. G., Magdy, M., Elgharib, A. M., Azzam, E. B., Nasser, F., Yousry, K., Shamkh, I. M., Mahdy, S. M., et al. (2021) · Molecules · doi:10.3390/molecules26216455 · Cited by 59
Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
Chen, J., Fan, J., Chen, Z., Zhang, M., Peng, H., Jian, L., Ding, L., Liu, M., Zhao, C., Zhao, P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111011118 · Cited by 59
Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape
Rochman, N. D., Faure, G., Wolf, Y. I., Freddolino, L., Zhang, F., & Koonin, E. V. (2022) · mBio · doi:10.1128/mbio.00135-22 · Cited by 59
Modular Label-Free Electrochemical Biosensor Loading Nature-Inspired Peptide toward the Widespread Use of COVID-19 Antibody Tests
de Castro, A. C. H., Bezerra, Í. R. S., Pascon, A. M., da Silva, G. H., Philot, E. A., de Oliveira, V. L., Mancini, R. S. N., Schleder, G. R., de Castro, C. E., Carvalho, L. R. S., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c04364 · Cited by 59
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
Dickey, T. H., Tang, W. K., Butler, B., Ouahes, T., Orr-Gonzalez, S., Salinas, N. D., Lambert, L., & Tolia, N. H. (2022) · Science Advances · doi:10.1126/sciadv.abq8276 · Cited by 59
A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites
Islam, M. J., Islam, N. N., Alom, M. S., Kabir, M., & Halim, M. A. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152302 · Cited by 59
SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis
Singal, C. M. S., Jaiswal, P., & Seth, P. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00251 · Cited by 59
Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling
Bednash, J. S., Kagan, V. E., Englert, J. A., Farkas, D., Tyurina, Y. Y., Tyurin, V. A., Самович, С. Н., Farkas, L., Elhance, A., Johns, F., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.10.007 · Cited by 59
Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EMPreprint
Liu, C., Yang, Y., Gao, Y., Shen, C., Ju, B., Liu, C., Tang, X., Wei, J., Ma, X., Liu, W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.02.972927 · Cited by 59
Current Perspective of Antiviral Strategies against COVID-19
Ahidjo, B. A., Loe, M. W. C., Ng, Y. L., Mok, C. K., & Chu, J. J. H. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00236 · Cited by 58
The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions
Silva-Filho, J. C., de Melo, C. G. F., & de Oliveira, J. L. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110155 · Cited by 58
Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study
Xiang, H.-X., Fei, J., Xiang, Y., Xu, Z., Zheng, L., Li, X.-Y., Fu, L., & Zhao, H. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05861-x · Cited by 58
Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients
Wulandari, L., Hamidah, B., Pakpahan, C., Damayanti, N. S., Kurniati, N. D., Adiatmaja, C. O., Wigianita, M. R., Soedarsono, S., Husada, D., Tinduh, D., et al. (2021) · Human Genomics · doi:10.1186/s40246-021-00330-7 · Cited by 58
Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs
Manček‐Keber, M., Hafner‐Bratkovič, I., Lainšček, D., Benčina, M., Govednik, T., Orehek, S., Plaper, T., Jazbec, V., Bergant, V., Grass, V., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100560r · Cited by 58
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58
Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen
Grishin, A. M., Dolgova, N. V., Landreth, S. L., Fisette, O., Pickering, I. J., George, G. N., Falzarano, D., & Cygler, M. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167357 · Cited by 58
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Greaney, A. J., Starr, T. N., Eguia, R. T., Loes, A. N., Khan, K., Karim, F., Cele, S., Bowen, J. E., Logue, J. K., Corti, D., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010248 · Cited by 58
Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination
Brasu, N., Elia, I., Russo, V., Montacchiesi, G., Stabile, S. A., Intinis, C. D., Fesi, F., Gizzi, K., Macagno, M., Montone, M., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01313-z · Cited by 58
Role of Spillover and Spillback in SARS-CoV-2 Transmission and the Importance of One Health in Understanding the Dynamics of the COVID-19 Pandemic
Sparrer, M. N., Hodges, N. F., Sherman, T. J., VandeWoude, S., Bosco‐Lauth, A. M., & Mayo, C. E. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01610-22 · Cited by 58
Blood group A enhances SARS-CoV-2 infection
Wu, S., Arthur, C. M., Jan, H.-M., García-Beltrán, W. F., Patel, K., Rathgeber, M. F., Verkerke, H., Cheedarla, N., Jajosky, R. P., Paul, A., et al. (2023) · Blood · doi:10.1182/blood.2022018903 · Cited by 58
Natural products and phytochemicals as potential anti‐SARS‐CoV ‐2 drugs
Mérarchi, M., Dudha, N., Das, B. C., & Garg, M. (2021) · Phytotherapy Research · doi:10.1002/ptr.7151 · Cited by 58
Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein
Tai, L., Zhu, G., Yang, M., Cao, L., Xing, X., Yin, G., Chan, C., Qin, C., Rao, Z., Wang, X., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112703118 · Cited by 58
Self-citation
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection
Ghafouri‐Fard, S., Noroozi, R., Omrani, M. D., Branicki, W., Pośpiech, E., Sayad, A., Pyrć, K., Łabaj, P. P., Vafaee, R., Taheri, M. N., et al. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106680 · Cited by 57
Relapsing viral keratoconjunctivitis in COVID-19: a case report
Guo, D., Xia, J., Wang, Y., Zhang, X., Shen, Y., & Tong, J. (2020) · Virology Journal · doi:10.1186/s12985-020-01370-6 · Cited by 57
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
Han, K., Blair, R. V., Iwanaga, N., Liu, F., Russell‐Lodrigue, K., Qin, Z., Midkiff, C. C., Golden, N., Doyle‐Meyers, L. A., Kabir, M. E., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0354oc · Cited by 57
DockCoV2: a drug database against SARS-CoV-2
Chen, T.-F., Chang, Y., Hsiao, Y., Lee, K.-H., Hsiao, Y.-C., Lin, Y.-H., Tu, Y.-C. E., Huang, H., Chen, C., & Juan, H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa861 · Cited by 57
New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release
Tomaszewski, T., DeVries, R. S., Dong, M., Bhatia, G., Norsworthy, M. D., Zheng, X., & Caetano‐Anollés, G. (2020) · Evolutionary Bioinformatics · doi:10.1177/1176934320965149 · Cited by 57
Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19
Patil, R. B., Chikhale, R. V., Khanal, P., Gurav, N. S., Ayyanar, M., Sinha, S. K., Prasad, S. K., Dey, Y. N., Wanjari, M., & Gurav, S. S. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100504 · Cited by 57
Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
Fournier, P., Colson, P., Levasseur, A., Devaux, C. A., Gautret, P., Bedotto, M., Delerce, J., Bréchard, L., Pinault, L., Lagier, J., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.068 · Cited by 57
Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2
Pavlova, À., Zhang, Z., Acharya, A., Lynch, D. L., Pang, Y. T., Mou, Z., Parks, J. M., Chipot, C. J., & Gumbart, J. C. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c01494 · Cited by 57
The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels
Sasson, A. M., Haas, J., Abuhasira, S., Sivan, M., Amdurski, H. D., Dadon, T., Blumenfeld, S., Derazne, E., Hemi, R., Orvieto, R., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab282 · Cited by 57
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
Chakraborty, S. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.075 · Cited by 58
A Broadband Biosensor Using Graphene-Metasurface Based Cross-Polarization Converter
Ghosh, S. K., Chaudhuri, A., Pal, P., Rai, B., Das, S., & Bhattacharyya, S. (2022) · IEEE Sensors Journal · doi:10.1109/jsen.2022.3176381 · Cited by 57
Advances in developing ACE2 derivatives against SARS-CoV-2
Zhang, H., Lv, P., Jiang, J., Liu, Y., Yan, R., Shu, S., Hu, B., Xiao, H., Cai, K., Yuan, S., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00011-3 · Cited by 57
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease
Pasala, C., Roychowdhury, T., Sharma, S., Moroni, E., Colombo, G., & Chiosis, G. (2024) · Biomolecules · doi:10.3390/biom14030282 · Cited by 57
Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes
Lu, R. X. Z., Rafatian, N., Zhao, Y., Wagner, K. T., Beroncal, E. L., Li, B., Lee, C. M., Chen, J., Churcher, E., Vosoughi, D., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk0164 · Cited by 57
SARS-CoV-2 spike protein: structure, viral entry and variants
Chen, B., Farzan, M., & Choe, H. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01185-8 · Cited by 57
Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
Chiba, S., Frey, S. J., Halfmann, P., Kuroda, M., Maemura, T., Yang, J. E., Wright, E., Kawaoka, Y., & Kane, R. S. (2021) · Communications Biology · doi:10.1038/s42003-021-02128-8 · Cited by 57
Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2
Johnson, T. O., Adegboyega, A. E., Iwaloye, O., Eseola, A. O., Plass, W., Afolabi, B., Rotimi, D., Ahmed, E. I., Albrakati, A., Batiha, G. E., et al. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.05.004 · Cited by 57
Expression and characterization of SARS-CoV-2 spike proteins
Schaub, J. M., Chou, C., Kuo, H., Javanmardi, K., Hsieh, C., Goldsmith, J. A., DiVenere, A. M., Le, K. C., Wrapp, D., Byrne, P. O., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00623-0 · Cited by 57
Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2
Ringlander, J., Fingal, J., Kann, H., Prakash, K., Rydell, G. E., Andersson, M., Martner, A., Lindh, M., Horal, P., Hellstrand, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112663119 · Cited by 57
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
Russo, G. L., Pennisi, M. A., Fichera, E., Motta, S., Raciti, G., Viceconti, M., & Pappalardo, F. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03872-0 · Cited by 56
Critical Differences between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV
Bai, C., & Warshel, A. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c04317 · Cited by 56
Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?
Morniroli, D., Giannì, M. L., Consales, A., Pietrasanta, C., & Mosca, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01480 · Cited by 56
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
Al‐Kassmy, J., Pedersen, J., & Kobinger, G. (2020) · Viruses · doi:10.3390/v12080861 · Cited by 56
SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations
Awadasseid, A., Wu, Y., Tanaka, Y., & Zhang, W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47827 · Cited by 56
Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain
Yang, J., Zhang, Z., Yang, F., Zhang, H., Wu, H., Zhu, F., & Xue, W. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13847 · Cited by 56
Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants’ interaction with ACE2 to understand the binding affinity and stability
Verma, J. K., & Subbarao, N. (2021) · Virology · doi:10.1016/j.virol.2021.06.009 · Cited by 56
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
Gupta, D., Sharma, P., Singh, M., Kumar, M., Ethayathulla, A. S., & Kaur, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04008-0 · Cited by 56
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern
Du, W., Hurdiss, D. L., Drabek, D., Mykytyn, A. Z., Kaiser, F. K., González-Hernández, M., Muñoz‐Santos, D., Lamers, M. M., van Haperen, R., Li, W., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abp9312 · Cited by 56
SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx
Kim, S. H., Kearns, F. L., Rosenfeld, M. A., Votapka, L. W., Casalino, L., Papanikolas, M., Amaro, R. E., & Freeman, R. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101346 · Cited by 56
Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management
Chavda, V. P., Bezbaruah, R., Ahmed, N., Alom, S., Bhattacharjee, B., Nalla, L. V., Rynjah, D., Gadanec, L. K., & Apostolopoulos, V. (2025) · Cells · doi:10.3390/cells14060400 · Cited by 56
Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins
Mansour, M. A., AboulMagd, A. M., & Abdel-Rahman, H. M. (2020) · RSC Advances · doi:10.1039/d0ra06424f · Cited by 56
Advanced Pulmonary and Cardiac Support of COVID-19 Patients
Rajagopal, K., Keller, S. P., Akkanti, B. H., Bime, C., Loyalka, P., Cheema, F. H., Zwischenberger, J. B., Banayosy, A. E., Pappalardo, F., Slaughter, M. S., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007175 · Cited by 55
Global SNP analysis of 11,183 SARS‐CoV‐2 strains reveals high genetic diversity
Yuan, F., Wang, L., Fāng, Y., & Wang, L. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13931 · Cited by 55
Accurate Evaluation on the Interactions of SARS-CoV-2 with Its Receptor ACE2 and Antibodies CR3022/CB6*
Ding, H.-M., Yin, Y., Ni, S.-D., Sheng, Y.-J., & Ma, Y. (2021) · Chinese Physics Letters · doi:10.1088/0256-307x/38/1/018701 · Cited by 55
The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis
Zhang, L., Hou, J., Ma, F.-Z., Li, J., Xue, S., & Xu, Z. (2021) · Archives of Virology · doi:10.1007/s00705-021-05012-2 · Cited by 55
Self-citation
Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies
Verkhivker, G. M., & Paola, L. D. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00395 · Cited by 55
N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in Plants
Shin, Y., König-Beihammer, J., Vavra, U., Schwestka, J., Kienzl, N. F., Klausberger, M., Laurent, E., Grünwald‐Gruber, C., Vierlinger, K., Hofner, M., et al. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.689104 · Cited by 55
Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen
Svobodová, M., Skouridou, V., Jauset‐Rubio, M., Viéitez, I., Fernández‐Villar, A., Cabrera, J. J., Poveda, E., Bofill, C. B., Sans, T., Bashammakh, A. S., et al. (2021) · ACS Omega · doi:10.1021/acsomega.1c05521 · Cited by 55
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Teixeira, L., Temerozo, J. R., Pereira-Dutra, F. S., Ferreira, A. C., Mattos, M., Gonçalves, B. S., Sacramento, C. Q., Palhinha, L., Cunha‐Fernandes, T., Dias, S. D. S. G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.820131 · Cited by 55
Covid-19: virology, variants, and vaccines
Young, M., Crook, H., Scott, J. T., & Edison, P. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2021-000040 · Cited by 55
Scanning the RBD-ACE2 molecular interactions in Omicron variant
Rath, S. L., Padhi, A. K., & Mandal, N. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.006 · Cited by 55
Structure-based investigation of a DNA aptamer targeting PTK7 reveals an intricate 3D fold guiding functional optimization
He, A., Wan, L., Zhang, Y., Yan, Z., Guo, P., Han, D., & Tan, W. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2404060121 · Cited by 55
Nanotraps for the containment and clearance of SARS-CoV-2
Chen, M., Rosenberg, J. N., Cai, X., Lee, A. C. H., Shi, J., Nguyen, M., Wignakumar, T., Mirle, V. R., Edobor, A., Fung, J. J., et al. (2021) · Matter · doi:10.1016/j.matt.2021.04.005 · Cited by 55
Aging and Options to Halt Declining Immunity to Virus Infections
Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.681449 · Cited by 55
Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
Mei, J., Zhou, Y., Yang, X., Zhang, F., Liu, X., & Yu, B. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114303 · Cited by 55
Multi-Modal Biological Destruction by Cold Atmospheric Plasma: Capability and Mechanism
Yan, D., Malyavko, A., Wang, Q., Ostrikov, K., Sherman, J. H., & Keidar, M. (2021) · Biomedicines · doi:10.3390/biomedicines9091259 · Cited by 55
Self-citation
Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition
Sanna, V., Satta, S., Hsiai, T. K., & Sechi, M. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114121 · Cited by 55
Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America
Gutiérrez, B., Castelán-Sánchez, H. G., Cândido, D. D. S., Jackson, B., Fleishon, S., Houzet, R., Ruis, C., Delaye, L., Faria, N. R., Rambaut, A., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.06.010 · Cited by 55
Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication?
Maiti, B. K. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00093 · Cited by 55
Update on the target structures of SARS-CoV-2: A systematic review
Medhi, B., Prajapat, M., Sarma, P., Shekhar, N., Prakash, A., Avti, P., Bhattacharyya, A., Kaur, H., Kumar, S., Bansal, S., et al. (2020) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_338_20 · Cited by 54
Minireview of progress in the structural study of SARS-CoV-2 proteins
Zhu, G., Zhu, C., Zhu, Y., & Sun, F. (2020) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2020.06.003 · Cited by 54
An update on the origin of SARS‐CoV‐2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O‐linked glycan residues
Malaiyan, J., Suresh, A., Mohan, K., & Radhakrishnan, G. G. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26261 · Cited by 54
Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective
Khatri, I., Staal, F. J. T., & van Dongen, J. J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570018 · Cited by 54
Beta-Sitosterol: As Immunostimulant, Antioxidant and Inhibitor of SARS-CoV-2 Spike Glycoprotein
Khan, S. L., & Siddiqui, F. A. (2020) · Archives of Pharmacology and Therapeutics · doi:10.33696/pharmacol.2.014 · Cited by 54
Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry
Plikusienė, I., Mačiulis, V., Ramanavičienė, A., Balevičius, Z., Bužavaitė‐Vertelienė, E., Čiplys, E., Slibinskas, R., Simanavičius, M., Žvirblienė, A., & Ramanavičius, A. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.02.100 · Cited by 54
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection
Favresse, J., Eucher, C., Elsen, M., Gillot, C., Eeckhoudt, S. V., Dogné, J., & Douxfils, J. (2021) · Microorganisms · doi:10.3390/microorganisms9030556 · Cited by 54
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
Centonze, D., Rocca, M. A., Gasperini, C., Kappos, L., Hartung, H.-P., Magyari, M., Oreja‐Guevara, C., Trojano, M., Wiendl, H., & Filippi, M. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10545-2 · Cited by 54
Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11
Fédry, J., Hurdiss, D. L., Wang, C., Li, W., Obal, G., Drulyte, I., Du, W., Howes, S. C., van Kuppeveld, F. J. M., Förster, F. G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf5632 · Cited by 54
Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor
Taka, E., Yilmaz, S. Z., Gölcük, M., Kılınç, C., Aktas, U., Yıldız, A., & Gür, M. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c02048 · Cited by 54
Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane
Schaefer, S. L., Jung, H., & Hummer, G. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c04176 · Cited by 54

Authors: Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X.
Affiliations: Tsinghua University (CN)
Chinese Academy of Sciences (CN)
Corresponding author: Zhang, Qi
Zhang, Linqi
Wang, Xinquan
ORCID: Lan, Jun
Ge, Jiwan
Yu, Jinfang
Shan, Sisi
Zhou, Huan
Fan, Shilong
Zhang, Qi
Shi, Xuanling
Wang, Qisheng
Zhang, Linqi
Wang, Xinquan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-03-30
Volume: 581
Issue: 7807
Pages: 215-220
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2180-5
OpenAlex: W3014067025
Cited by: 5,983
References: 38
Citations by year: 2026: 207 · 2025: 404 · 2024: 573 · 2023: 797 · 2022: 1237 · 2021: 1678 · 2020: 1076
FWCI: 152.41
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Salt Science Research Foundation
Tencent
Tsinghua University (20201080053)
Beijing Municipal Science and Technology Commission (171100000517-001 and -003)
Beijing Advanced Innovation Center for Structural Biology, Tsinghua University
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: SARS-CoV-2, spike protein, receptor binding domain, ACE2, crystal structure, SARS-CoV, convergent evolution, antibody epitopes, cross-reactive antibodies, viral entry, binding site residues
MeSH terms: Protein Domains, Betacoronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Amino Acid Sequence, Epitopes, Binding Sites, Humans, Hydrogen Bonding, Peptidyl-Dipeptidase A, Models, Molecular, Protein Binding, Receptors, Virus, Salts, Water, Sequence Alignment, Conserved Sequence, Crystallography, X-Ray, Evolution, Molecular, Severe acute respiratory syndrome-related coronavirus, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks